2C-iP

2C-iP
Clinical data
Other names	4-Isopropyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-isopropylphenethylamine; Jelena; Momento
Routes of; administration	Oral
Drug class	Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Class A;
Pharmacokinetic data
Duration of action	8–12 hours
Identifiers
	IUPAC name 2-[2,5-dimethoxy-4-(propan-2-yl)phenyl]ethan-1-amine;
CAS Number	1498978-47-4;
PubChem CID	57474311;
ChemSpider	27750188;
UNII	4TT057Y1ST;
CompTox Dashboard (EPA)	DTXSID301032631 ;
Chemical and physical data
Formula	C13H21NO2
Molar mass	223.316 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=C(C=C(C(=C1)C(C)C)OC)CCN;
	InChI InChI=1S/C13H21NO2/c1-9(2)11-8-12(15-3)10(5-6-14)7-13(11)16-4/h7-9H,5-6,14H2,1-4H3; Key:XUGPCRRUMVWELT-UHFFFAOYSA-N;

2C-iP, also known as 4-isopropyl-2,5-dimethoxyphenethylamine or as Jelena or Momento, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally. The drug was first described by 2011 and was encountered as a novel designer drug by 2018.